Wordt geladen...
The efficacy and safety of riluzole for neurodegenerative movement disorders: a systematic review with meta-analysis
Neurodegenerative movement disorders mainly include Parkinson’s disease, atypical parkinsonisms, Huntington disease, and hereditary ataxia. Riluzole is the only drug approved by the US Food and Drug Administration for amyotrophic lateral sclerosis. The neuroprotective effects of riluzole have been o...
Bewaard in:
| Gepubliceerd in: | Drug Deliv |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6058579/ https://ncbi.nlm.nih.gov/pubmed/29226728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2017.1413446 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|